NOS2 and breast carcinoma: Garrido et al. reported that iNOS was involved in the activation of epidermal growth factor receptor (EGFR) and the accumulation of p53 mutation in breast cancer cell lines; in addition, iNOS overexpression was proven to correlate with disease recurrence, distant metastasis, and reduced CSS in breast cancer patients [11].